Novo Nordisk faces potential layoffs after a period of rapid expansion fueled by the success of Wegovy. The company's workforce nearly doubled in five years, but slowing sales and increased ...

A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits totaling more than $2 billion circulated online in August 2025.

Worker-led protests erupted at Microsoft headquarters this week as the tech company promises an “urgent” review of the ...

Novo Nordisk, the Denmark-based pharmaceutical company that makes Ozempic and Wegovy, looks like it's being toppled off its ...

The cost of the weight-loss drug is set to soar by 170pc, but there are steps you can take to mitigate the rise ...

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's popular weight-loss drug Wegovy to treat a serious ...

GoodRx and Novo Nordisk are partnering to lower costs for Ozempic and Wegovy. Patients can use GoodRx to access ...

Turmeric and curcumin may offer modest benefits for weight management in people with prediabetes and type 2 diabetes, a new ...

The move is likely part of the company’s goal to reduce costs as it faces increased competition in the GLP-1 space.